Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio

    • Current page: News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

Synthesia increases valuation to $4bn, powering the UK’s AI ambition

AI video company Synthesia, co-founded from UCL’s Department of Computer Science, has nearly doubled its valuation following a major funding round.

27 January 2026

Synthesia increases valuation to $4bn

Breadcrumb trail

  1. Home
  2. News & events
  3. News & views
  4. Synthesia increases valuation to $4bn, powering the UK’s AI ambition

Its latest $200m Series E raise, led by Alphabet’s Google Ventures with participation from Nvidia’s venture arm and longstanding investors, lifted the company’s valuation from around $2.1bn to $4bn in just a year, cementing its position as one of the UK’s most valuable private AI companies.

From UCL research to global AI scaleup

Today, Synthesia provides AI-generated video and avatar technology worldwide, with customers spanning global and public sector organisations, including 70% of the FTSE 100. But its roots stem from university research, being co-founded by Professor Lourdes Agapito of UCL Computer Science.

This is another step in an already-impressive journey: in 2021, the company raised a $12.5m Series A round of funding, and two years later, after a Series C fundraiser of $90m, Synthesia [became a ‘unicorn’, a privately held firm valued at $1bn.

The new valuation puts the company broadly on a par with Moonshot AI, which was valued at $4.8bn after a recent funding round backed by Alibaba and Tencent. This underlines the growing impact of university-born deep tech in the UK and how rapidly university originated AI businesses can now scale.

Supporting Euston’s Knowledge Quarter

The milestone comes as new analysis from UCL and Public First highlights how the life science and technology district around Euston and King’s Cross, already home to Synthesia, [could add £3.5bn a year to the UK economy](https://www.ucl.ac.uk/news/2026/jan/ai-powered-life-science-district-could-add-ps35bn-uk-economy-modelled-bostons-kendall) if it scales on a trajectory similar to Boston’s Kendall Square.

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Business Ltd